文献速递复苏、休克与脓毒症心脑血管急症

肾上腺素在院外心脏骤停中的应用:网络Meta分析与可除颤及不可除颤心律的亚组分析

Epinephrine in Out-of-Hospital Cardiac Arrest: A Network Meta-analysis and Subgroup Analyses of Shockable and Nonshockable Rhythms.
PubMed 文献 · Chest · 2023-01-31
一句话结论标准剂量肾上腺素、大剂量肾上腺素及肾上腺素联合血管加压素均提高院外心脏骤停患者ROSC和入院存活率,但可能不改善出院存活或功能结局;标准剂量肾上腺素改善不可除颤心律患者的出院存活,对可除颤心律患者无改善。

本研究为系统评价与网络Meta分析,纳入18项随机对照试验共21594例院外心脏骤停患者,比较标准剂量肾上腺素、大剂量肾上腺素、肾上腺素联合血管加压素与安慰剂或不治疗的效果。结果显示,与安慰剂或不治疗相比,三种肾上腺素方案均提高ROSC和入院存活率,但均可能不改善出院存活或良好功能结局。亚组分析显示,标准剂量肾上腺素改善不可除颤心律患者的出院存活(OR 2.10;95%CI 1.21-3.63),但对可除颤心律患者无改善(OR 0.85;95%CI 0.39-1.85)。

要点

  • 与安慰剂或不治疗相比,标准剂量肾上腺素提高ROSC(OR 3.69;95%CI 3.32-4.10)和入院存活(OR 3.00;95%CI 2.66-3.38)。
  • 大剂量肾上腺素提高ROSC(OR 4.27;95%CI 3.68-4.97)和入院存活(OR 3.53;95%CI 2.97-4.20)。
  • 肾上腺素联合血管加压素提高ROSC(OR 3.54;95%CI 2.94-4.26)和入院存活(OR 2.79;95%CI 2.27-3.44)。
  • 与安慰剂或不治疗相比,上述药物均可能不改善出院存活或良好功能结局。
  • 标准剂量肾上腺素改善不可除颤心律患者的出院存活(OR 2.10;95%CI 1.21-3.63),对可除颤心律患者无改善(OR 0.85;95%CI 0.39-1.85)。

适用人群与场景

  • 院外心脏骤停(OHCA)接受复苏的患者,纳入随机对照试验评估复苏期间肾上腺素使用。

研究设计与关键结果

  • 系统评价与网络Meta分析纳入18项随机对照试验,共21594例患者,检索六个数据库从建库至2022年6月。
  • 与安慰剂或不治疗相比,大剂量肾上腺素(OR 4.27;95%CI 3.68-4.97)、标准剂量肾上腺素(OR 3.69;95%CI 3.32-4.10)、肾上腺素联合血管加压素(OR 3.54;95%CI 2.94-4.26)均提高ROSC。
  • 与安慰剂或不治疗相比,大剂量肾上腺素(OR 3.53;95%CI 2.97-4.20)、标准剂量肾上腺素(OR 3.00;95%CI 2.66-3.38)、肾上腺素联合血管加压素(OR 2.79;95%CI 2.27-3.44)均提高入院存活率。
  • 与安慰剂或不治疗相比,上述药物均可能不改善出院存活或良好功能结局。
  • 亚组分析:标准剂量肾上腺素改善不可除颤心律患者的出院存活(OR 2.10;95%CI 1.21-3.63),对可除颤心律患者无改善(OR 0.85;95%CI 0.39-1.85)。

证据类型、等级与局限

  • 证据类型:系统评价与网络Meta分析(随机对照试验)。
  • 采用GRADE方法评级证据确定性。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于OHCA患者,标准剂量肾上腺素、大剂量肾上腺素及肾上腺素联合血管加压素可提高ROSC和入院存活率,但可能不改善出院存活或功能结局。
  • 作者认为,标准剂量肾上腺素改善不可除颤心律患者的出院存活,但对可除颤心律患者无改善。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Epinephrine is the most commonly used drug in out-of-hospital cardiac arrest (OHCA) resuscitation, but evidence supporting its efficacy is mixed.

RESEARCH QUESTION: What are the comparative efficacy and safety of standard dose epinephrine, high-dose epinephrine, epinephrine plus vasopressin, and placebo or no treatment in improving outcomes after OHCA?

STUDY DESIGN AND METHODS: In this systematic review and network meta-analysis of randomized controlled trials, we searched six databases from inception through June 2022 for randomized controlled trials evaluating epinephrine use during OHCA resuscitation. We performed frequentist random-effects network meta-analysis and present ORs and 95% CIs. We used the the Grading of Recommendations, Assessment, Development, and Evaluation approach to rate the certainty of evidence. Outcomes included return of spontaneous circulation (ROSC), survival to hospital admission, survival to discharge, and survival with good functional outcome.

RESULTS: We included 18 trials (21,594 patients). Compared with placebo or no treatment, high-dose epinephrine (OR, 4.27; 95% CI, 3.68-4.97), standard-dose epinephrine (OR, 3.69; 95% CI, 3.32-4.10), and epinephrine plus vasopressin (OR, 3.54; 95% CI, 2.94-4.26) all increased ROSC. High-dose epinephrine (OR, 3.53; 95% CI, 2.97-4.20), standard-dose epinephrine (OR, 3.00; 95% CI, 2.66-3.38), and epinephrine plus vasopressin (OR, 2.79; 95% CI, 2.27-3.44) all increased survival to hospital admission as compared with placebo or no treatment. However, none of these agents may increase survival to discharge or survival with good functional outcome as compared with placebo or no treatment. Compared with placebo or no treatment, standard-dose epinephrine improved survival to discharge among patients with nonshockable rhythm (OR, 2.10; 95% CI, 1.21-3.63), but not in those with shockable rhythm (OR, 0.85; 95% CI, 0.39-1.85).

INTERPRETATION: Use of standard-dose epinephrine, high-dose epinephrine, and epinephrine plus vasopressin increases ROSC and survival to hospital admission, but may not improve survival to discharge or functional outcome. Standard-dose epinephrine improved survival to discharge among patients with nonshockable rhythm, but not those with shockable rhythm.

TRIAL REGISTRY: Center for Open Science: https://osf.io/arxwq.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Fernando SM, Mathew R, Sadeghirad B, et al. Epinephrine in Out-of-Hospital Cardiac Arrest: A Network Meta-analysis and Subgroup Analyses of Shockable and Nonshockable Rhythms. Chest. 2023. PMID: 36736487. doi:10.1016/j.chest.2023.01.033

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。